top of page

Protuoso Biosciences exited stealth this past week with the goal of developing multifunctional MUXBODY biologics, fusion proteins that integrate diverse modalities into a single therapy

Jun 4
1 min read

Co-Founder & CEO Willie Xiang discusses the platform and the company's progress to getting them into the clinic. Current programs target cardiometabolic diseases and solid tumors.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page